Completes investment in company and assumes role of President & CEO to drive commercialization strategy for Retina Labs expanded teleophthalmology product suite
MONTREAL, QUEBEC – Retina Labs, a market innovator in teleophthalmology and virtual eye care solutions, has brought on Richard Pridham as its President and CEO and as an investor in the company. Richard’s most recent position was Founder and CEO of Agility Metrics, a Voice of the Customer solutions provider (acquired by Leger Marketing). At Retina Labs he will be responsible for leading strategy, marketing and sales for the company’s teleophthalmology, EMR, Practice Management, eReferral solutions.
Richard brings to Retina Labs a wealth of entrepreneurial business experience in the technology and healthcare sectors and will be the driving force behind the company’s growth plans. “Richard’s experience working with healthcare organizations and retail eye wear chains will be an invaluable asset to the company”, says Hamid Fotuhi, Retina Labs co-founder and COO.
“I am excited to be part of the Retina Labs team” says Richard. “Access to timely eye care continues to be in a crisis in North America, especially for patients suffering from chronic eye diseases and ones in remote locations. As an R&D focused company, Retina Labs has been a true pioneer in the field of teleophthalmology and ensures that patients are seen by appropriate eye care professionals and receive continuous access to convenient, high quality eye care. The growing demand for telehealth solutions represents a huge opportunity for the company”, concludes Richard.
About Retina Labs
For over a decade, Retina Labs has been on the leading edge of telehealth and virtual care innovation. Its cloud-based iVision® teleophthalmology platform offers eye care professionals an integrated solution that combines advanced ocular imaging, clinical interpretation and reporting tools with integrated Electronic Medical Records, Practice Management and electronic referrals. The company’s solutions allow healthcare providers to improve access to quality eye care while streamlining the processes related to the management of chronic eye diseases such as diabetic retinopathy, glaucoma, age related macular degeneration and retinopathy of prematurity. iVision is the teleophthalmology platform of choice for hospitals, government health agencies and eye care professionals, and is recognized by the World Health Organization for its breakthrough advancements in telehealth technology. For more information on Retina Labs visit www.retina-labs.com.
.jpg)
